Pitsikas N - Search Results

1

Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders.

Cereda E, Brambilla A, Ezhaya A, Gaida W, Mendla K, Monferini E, Pitsikas N, Schiavi GB, Sagrada A. Cereda E, et al. Among authors: pitsikas n. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):179-83. doi: 10.1007/BF03188919. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867659

2

Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Pharmacol Biochem Behav. 1994 Jan;47(1):95-9. doi: 10.1016/0091-3057(94)90116-3. Pharmacol Biochem Behav. 1994. PMID: 8115433

3

DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Neurobiol Aging. 1993 Nov-Dec;14(6):561-4. doi: 10.1016/0197-4580(93)90039-e. Neurobiol Aging. 1993. PMID: 8295658

4

Behavioral effects of flibanserin (BIMT 17).

Borsini F, Brambilla A, Grippa N, Pitsikas N. Borsini F, et al. Among authors: pitsikas n. Pharmacol Biochem Behav. 1999 Sep;64(1):137-46. doi: 10.1016/s0091-3057(99)00072-6. Pharmacol Biochem Behav. 1999. PMID: 10495008

5

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats.

Brambilla A, Ghiorzi A, Pitsikas N, Borsini F. Brambilla A, et al. Among authors: pitsikas n. J Pharm Pharmacol. 1993 Sep;45(9):841-3. doi: 10.1111/j.2042-7158.1993.tb05698.x. J Pharm Pharmacol. 1993. PMID: 7903377

6

Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.

Pitsikas N, Brambilla A, Besozzi C, Bonali P, Fodritto F, Grippa N, Scandroglio A, Borsini F. Pitsikas N, et al. Pharmacol Biochem Behav. 2001 Mar;68(3):443-7. doi: 10.1016/s0091-3057(00)00469-x. Pharmacol Biochem Behav. 2001. PMID: 11325397

7

The adenosine A1 receptor antagonist BIIP 20 counteracts scopolamine-induced behavioral deficits in the passive avoidance task in the rat.

Pitsikas N, Borsini F. Pitsikas N, et al. Eur J Pharmacol. 1997 Jun 5;328(1):19-22. doi: 10.1016/s0014-2999(97)83021-x. Eur J Pharmacol. 1997. PMID: 9203562

8

Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance task.

Pitsikas N, Borsini F. Pitsikas N, et al. Eur J Pharmacol. 1996 Sep 12;311(2-3):115-9. doi: 10.1016/0014-2999(96)00586-9. Eur J Pharmacol. 1996. PMID: 8891590

9

Different effects of tropisetron and ondansetron in learning and memory paradigms.

Pitsikas N, Borsini F. Pitsikas N, et al. Pharmacol Biochem Behav. 1997 Apr;56(4):571-6. doi: 10.1016/s0091-3057(96)00516-3. Pharmacol Biochem Behav. 1997. PMID: 9130279

10

Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.

Pitsikas N, Rigamonti AE, Cella SG, Locatelli V, Sala M, Muller EE. Pitsikas N, et al. Eur J Pharmacol. 2001 Aug 31;426(3):193-200. doi: 10.1016/s0014-2999(01)01164-5. Eur J Pharmacol. 2001. PMID: 11527544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters